Publications

publicationpublibook


2017

  • Pro-differentiating effects of a synthetic flavagline on human teratocarcinomal cancer stem-like cells.
    Emhemmed F., Ali Azouaou S., Zhao Q., Appert-Collin A., Bennasroune A., Schini-Kerth V.B., Muller C.D., Désaubry L., Fuhrmann G.
    Cell Biol Toxicol.
    , 2017, ASAP

2016

  • A general and efficient synthesis of 2-pyridones, 2-quinolinones and 1-isoquinolinones from azine-N-oxides.
    Wang D., Zhao J., Wang Y., Hu J., Li L., Miao L., Feng H., Désaubry L;, Yu P.
    Asian J. Org. Chem.
    2016, 5, 1442-1446

  • Molecular pathways: the eIF4F translation initiation complex –new opportunities for cancer treatment.
    Malka-Mahieu H., Newman M., Désaubry L., Robert C., Vagner S.
    Clin Cancer Res.
    , 2016, 22, in press

  • Synergistic effects of eIF4A and MEK inhibitors on proliferation of NRAS-mutant melanoma cell lines.
    Malka-Mahieu H., Girault I., Rubington M., Leriche M., Welsch C., Kamsu-Kom N., Zhao Q., Désaubry L., Vagner S., Robert C.
    Cell cycle
    , 2016, 15, 2405-2409

  • Synthesis of hydroxybenzofurans by condensation of quinones with benzoylacetone: revised structure of the adducts.
    Hammoud H., Zhao Q., Désaubry L. 
    Tetrahedron Lett., 2016,
    57, 4044–4045

  • Recent advances in the synthesis of flavaglines, a family of potent bioactive natural compounds coming from traditional Chinese medicine.
    Zhao Q., Abou-Hamdan H., Désaubry L.
    Eur. J. Org. Chem.
    , 2016, 5908-5916

  • STAT1 Promotes KRAS Colon Tumor Growth and Susceptibility to Pharmacological Inhibition of Translation Initiation Factor eIF4A.
    Wang S, Darini C, Désaubry L, Koromilas AE.
    Mol Cancer Ther.
    , 2016,  15, 3055-3063

  • Bioisosteric modification of flavaglines
    Qian Z., Tijeras-Raballand A., de Gramont A., Raymond E., Désaubry L.
    Tetrahedron Lett.
    , 2016, 57, 2943

  • Flavaglines ameliorate experimental colitis and protect against intestinal epithelial cell apoptosis and mitochondrial dysfunction.
    Han J., Zhao Q., Basmadjian C., Désaubry L., Theiss A.L.
    Inflamm. Bowel Dis
    . 2016, 22, 55-67

 

 


2015

  • FL3, a synthetic flavagline and ligand of prohibitins, protects cardiomyocytes via STAT3 from doxorubicin toxicity.
    Qureshi R, Yildirim O, Gasser A, Basmadjian C, Zhao Q, Wilmet J-P, Désaubry L., Nebigil C.G.
    PLOS One
    2015, 10(11): e0141826.

  • Discovery and cardioprotective effects of the first non-peptide agonists of the G protein-coupled prokineticin receptor-1.
    Gasser A., Brogi S., Urayama K., Nishi T., Kurose H., Tafi A., Ribeiro N., Désaubry L., Nebigil CG.
    Plos One.
    2015, 10, e0121027

  • Revision of the synthesis and pharmacological activity of a reported translation inhibitor.
    Basmadjian C., Malka-Mahieu H., Désaubry L.
    Anticancer Agents Med. Chem.
    2015, 15, 1305-1307
  • Flavaglines stimulate transient receptor potential melastatin type 6 (TRPM6) channel activity.
    Blanchard MG., de Baaij J.H.F., Verkaart S.A.J., Lameris A.L., Basmadjian C., Zhao Q., Désaubry L., Bindels R.J.M., Hoenderop JG.
    Plos One 2015, 10, e0119028.
  • Assessment of flavaglines as potential chikungunya virus entry inhibitors.
    Wintachai, P.; Thuaud, F.; Basmadjian, C.; Ubol, S.; Désaubry, L.; Smith, D.R.
    Microbiol. Immunol. 2015, 59, 129-141

  • Exploratory studies toward a synthesis of flavaglines . A novel access to a highly substituted. cyclopentenone intermediate
    Basmadjian, C.; Zhao, Q.; Désaubry, L.
    Tetrahedron Lett.
    2015, 56, 727–730.


2014

  • eIF4F is a key and targetable convergence nexus of multiple resistance mechanisms to anti-RAF and anti-MEK cancer therapies.
    Boussemart, L.; Malka-Mahieu, H.; Girault, I.; Allard, D.; Hemmingsson, O.; Tomasic, G.; Thomas, M.; Basmadjian, C.; Ribeiro, N.; Thuaud, F.; Mateus, C.; Routier, E.; Kamsu-Kom, N.; Agoussi, S.; Eggermont, A. M.; Désaubry, L.; Robert, C.; Vagner, S.
    Nature 2014, 513, 105–109.

  • Benzofuran derivatives as anticancer inhibitors of mTOR signaling.
    Salomé, C.; Ribeiro, N.; Chavagnan, T.; Thuaud, F.; Serova, M.; de Gramont, A.; Faivre, S.; Raymond, E.; Désaubry, L.
    Eur. J. Med. Chem.
    2014, 81, 181–191.

  • Cancer wars: natural products strike back.
    Basmadjian, C.; Zhao, Q.; Bentouhami, E.; Djehal, A.; Nebigil, C. G.; Johnson, R. A.; Serova, M.; de Gramont, A.; Faivre, S.; Raymond, E.; Désaubry, L. G.
    Front. Chem.
    2014, 2, 20.

  • Selective anticancer effects of a synthetic flavagline on human Oct4-expressing cancer stem-like cells via a p38 MAPK-dependent caspase-3-dependent pathway.
    Emhemmed, F.; Ali Azouaou, S.; Thuaud, F.; Schini-Kerth, V.; Désaubry, L.; Muller, C. D.; Fuhrmann, G.
    Biochem. Pharmacol. 2014, 89, 185–196.

  • Benzofuran derivatives as a novel class of inhibitors of mTOR signaling.
    Salomé, C.; Narbonne, V.; Ribeiro, N.; Thuaud, F.; Serova, M.; de Gramont, A.; Faivre, S.; Raymond, E.; Désaubry, L.
    Eur. J. Med. Chem.
    2014, 74, 41–49.


2013

  • N-[3a-(4-Bromophenyl)-8b-hydroxy-6,8-dimethoxy-3-phenyl-2,3,3a,8b-tetrahydro-1H-cyclopenta[b ]benzofuran-1-yl]formamide monohydrate.
    Aubert M., Thuaud F., Ribeiro N., Désaubry L., Espinosa E.
    Acta Cryst. E
     
    2013, 69, o52-o53
  • Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential,
    Thuaud F, Ribeiro N, Nebigil CG, Désaubry L.
    Chem Biol.
    2013, 20, 316-331

2012

  • Cytochromes P450 CYP94C1 and CYP94B3 catalyze two successive oxidation steps of plant hormone Jasmonoyl-isoleucine for catabolic turnover.
    Heitz, T.; Widemann, E.; Lugan, R.; Miesch, L.; Ullmann, P.; Désaubry, L.; Holder, E.; Grausem, B.; Kandel, S.; Miesch, M.; Werck-Reichhart, D.; Pinot, F.
    J. Biol. Chem.
    2012, 287, 6296–6306.
  • The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2.
    Polier, G.; Neumann, J.; Thuaud, F.; Ribeiro, N.; Gelhaus, C.; Schmidt, H.; Giaisi, M.; Köhler, R.; Müller, W. W.; Proksch, P.; Leippe, M.; Janssen, O.; Désaubry, L.; Krammer, P. H.; Li-Weber, M.
    Chem. Biol.
    2012, 19, 1093–1104.
  • Flavaglines as potent anticancer and cytoprotective agents.
    Ribeiro, N.; Thuaud, F.; Bernard, Y.; Gaiddon, C.; Cresteil, T.; Hild, A.; Hirsch, E. C.; Michel, P. P.; Nebigil, C. G.; Désaubry, L.
    J. Med. Chem.
    2012, 55, 10064–10073.
1!-- CONTENT ELEMENT, uid:82222/div [begin] -->

2!-- CONTENT ELEMENT, uid:88483/text [begin] -->i cldiv id="c82221" class="csc-defaul1">

2016

  • FL3, a synthetic flavaanticancer A P.vsmad D/strong>57, 4044–4>57, 4044–4 ONE>57, 4044–4 -- 1i> , e25302 (-- 1)

    Selectivehref="htI> me eIF4F tw

1 1div class="csc-default">

1!-- CONTENT ELEMENT, uid:82227/text [begin] --> 1

2015

2010 et avan>2010 et ava-> 1 66135/>o52d="c82227" class="csc-def66135> Raw HTML stract?2015A tualnsng>">A tualnsng> Raw HTML stract? 66135/>o52d=NTENT ELEME>dd="contental 66134 Msid="c82227" class="csc-def66134> Plu822 insebito2015 ba746cba844281f3eahiation">B> 2v- t aux nouvCaux mistrf EK l'unnsng!!!"Ego-unistra" 6"6" add="contentndsu-imagf"0;">01invisible-xs invisiblmoi(">octob, 2v- t aux nouvCaux mistrf EK l'unnsng!!!- h3ss="col-sm-6"6"6" add="contentndsu- esc"Ego-unistra" 6"6" ntheC'esul> 2v- t aux nouvCaux mistrf EK l'unnsng à savoir> Dép.L.,à ln intraitomd'Angèle M.;oenfelapologo-unistra" 6"6" add="contentndsu-imagf"0;">30invisible-xs invisiblmoi(">statemb, on 2v-r( ssslsollègues, Angèle a décidé EK neendre une> i7- ader:le-xs invisiblmoi(">statemb, Stras03- ader:le-xs invisiblmoi(">juillet: Etuds phyturLinket- /ul4-5521bet- dK-depeules sou Conf200ei-RAPr Rostrd J QUINN (GriffevisUniv338nslaof Brisbyat > Au2%29lie)pbgo-unistra" 6"6" add="contentndsu-imagf"0;">21invisible-xs invisiblmoi(">juin Au2%29lie)- h3ss="col-sm-6"6"6" add="contentndsu- esc"Ego-unistra" 6"6" nthe14h00 « Npounds P/stronchemigetgiv> eBased Drug Disceitze flavT the hI> »Lieu: Salle> Conf200ei-RAPr Gangarajuln Sudhakar (CSIR-Indis iInsne itpeuting>20invisible-xs invisiblmoi(">juinach57 Conf200ei-RADr 0Tom Podewemi(Max Plti-kiInsne itpee Me
i3- ader:le-xs invisiblmoi(">juinotoity of a rey revisi>oto(revchs of PtatMEK- 13h dan l'_83hi>i2- ader:le-xs invisiblmoi(">juin: NouvClptseciblf pour l’étuds e hof dngveloppdiv> lE’, N.l pty of a repet-smoriginaux> 01invisible-xs invisiblmoi(">juin l«IdExsat%2900ransng" pour Iuliia e hunl«IdExspost-doctorant" pour> n SALACZ reçoi hof prix EK-Eédit ava DUNOD"Ego-unistra" 6"6" add="contentndsu-imagf"0;">n.png)"itedlass="col-sm-6"6"6" add="contentndsu- danrga00000rcher d tit">i2- ader:le-xs invisiblmoi(">main SALACZ reçoi hof prix EK-Eédit ava DUNOD - h3ss="col-sm-6"6"6" add="contentndsu- esc"Ego-unistra" 6"6" nthepour sa communs
01invisible-xs invisiblmoi(">maigetiçoise Hervisreçoi hoa médaille d'h; Thur du CNRSlogo-unistra" 6"6" add="contentndsu-imagf"0;">24invisible-xs invisiblmoi(">janv Th/evisible-xs invisibl lton 2gagfiv> !!!- pss="col-sm-6"6"6" a[dlass="col-sm-6"6"6" a[abgo-unistra" 6"6" [dlass="col-smgo-unistra stra" 6"6"go-unistra" 6"6"go-unistra" 6"6" dd="contentndsu"Ego-unistra" 6"6" anique-med tualns-(td tualns-/?tx_ttnews%5Btt_news%5D=150007_837cHash=907dcb673fa3f160d09ce4b57152ab27 publicatFélbcit ,à Ssngptynie R, Cé5pour sa promor /> diche-9680ovenonteliSupérihuripbgo-unistra" 6"6" add="contentndsu-imagf"0;">01invisible-xs invisiblmoi(">janv Th/evisible-xs invisibl diche-9680ovenonteliSupérihuri- h3ss="col-sm-6"6"6" add="contentndsu- esc"Ego-unistra" 6"6" nthe- pss="col-sm-6"6"6" a[dlass="col-sm-6"6"6" a[abgo-unistra" 6"6" [dlass="col-smgo-unistra stra" 6"6"go-unistra" 6"6"go-unistra" 6"6" dd="contentndsu"Ego-unistra" 6"6" anique-med tualns-(td tualns-/?tx_ttnews%5Btt_news%5D=141117_837cHash=371d6143f25a89bd4f31fca12d7b5c8chiation">Dr. D.iB; Tht obN.;n hunlfi; 08div> lEK l’ANRl« Innovbr /> Bioméd>01invisible-xs invisiblmoi(">janv Th/evisible-xs invisibl lEK l’ANRl« Innovbr /> Bioméd> lEK l’Agei-RANbr />ale EK la h-box" cl (ANR)l« Innovbr />> Deux P/ix5pour MigilBoogTebach5en /li6"Ego-unistra" 6"6" add="contentndsu-imagf"0;">30invisible-xs invisiblmoi(">décemb, Dép.L.,à ln intraitomd'Yveance R,val"Ego-unistra" 6"6" add="contentndsu-imagf"0;">i6invisible-xs invisiblmoi(">décemb, 2 du soleillEK ton sgilnhimi!!!- pss="col-sm-6"6"6" a[dlass="col-sm-6"6"6" a[abgo-unistra" 6"6" [dlass="col-smgo-unistra stra" 6"6"go-unistra" 6"6"go-unistra" 6"6" dd="contentndsu"Ego-unistra" 6"6" anique-med tualns-(td tualns-/?tx_ttnews%5Btt_news%5D=141057_837cHash=1c00dde70ab6c82c0295c001c5cfb869ication">Deux P/ix5du Meilleur Poster5en /li6lpour Lu968 Esteoullipbgo-unistra" 6"6" add="contentndsu-imagf"0;">06invisible-xs invisiblmoi(">décemb, <,à> Sout- ti-RAdl TulocaAdl Tuomas Caonanheiro : Bravo Docteur!!!"Ego-unistra" 6"6" add="contentndsu-imagf"0;">02- ader:le-xs invisiblmoi(">décemb, ptooRé900rava Dominot Pharmac-induns-( Dr Jean-Jacet-smBourguignon reçoi hof prix Camille Wermuth5EK la société Brng>il680oveEK y/pube méd>27- ader:le-xs invisiblmoi(">novemb, il680oveEK y/pube méd>Dép.L.,à ln intraitomd- notre oesu naire : irofns- b> 2 notre cllore Fetiçoise!!!"Ego-unistra" 6"6" add="contentndsu-imagf"0;">i5- ader:le-xs invisiblmoi(">novemb, 2 notre cllore Fetiçoise!!!- h3ss="col-sm-6"6"6" add="contentndsu- esc"Ego-unistra" 6"6" ntheEt mercilpour tout!!!!- pss="col-sm-6"6"6" a[dlass="col-sm-6"6"6" a[abgo-unistra" 6"6" [dlass="col-smgo-unistra stra" 6"6"go-unistra" 6"6"go-unistra" 6"6" dd="contentndsu"Ego-unistra" 6"6" anique-med tualns-(td tualns-/?tx_ttnews%5Btt_news%5D=137787_837cHash=81a8ffc82cc89ab21b15f6bce4c401f9ication">Meilleursposter5pour Jean-Baptiste Grmaé 9th5Comacet- Internbr />al EK-EPltis-( Arost/>et-ai4invisible-xs invisiblmoi(">novemb, al EK-EPltis-( Arost/>et-aSout- ti-RAdl tulocaAdl Sarah Blouin : Félbcit !!!"Ego-unistra" 6"6" add="contentndsu-imagf"0;">21invisible-xs invisiblmoi(">octob, ptooré900rava en tascads prmaado-ochimie01invisible-xs invisiblmoi(">octob, Visitomdu 1-- tnistre ManuellVrmas sur ln tampus d'Illkirchpbgo-unistra" 6"6" add="contentndsu-imagf"0;">02- ader:le-xs invisiblmoi(">statemb, MeilleursPoster5REGIO 36lpour Sarah Blouinpbgo-unistra" 6"6" add="contentndsu-imagf"0;">01invisible-xs invisiblmoi(">statemb, maître de conf200ei-RAà ln faculté EK pus="blifAdl Stras01invisible-xs invisiblmoi(">statemb, maître de conf200ei-RAà ln faculté EK pus="blifAdl StrasB; Th01invisible-xs invisiblmoi(">janv Th/evisible-xs invisibl allrapeu/>et- vou( souhait;n hunelheuriuse P/ix5EK allocamde l'Acadé tRANbr />ale EK Pus="bliflpour Christnce Basmadjis i7_837 Iuliia Karpenko"Ego-unistra" 6"6" add="contentndsu-imagf"0;">06invisible-xs invisiblmoi(">novemb, ale EK Pus="bliflpour Christnce Basmadjis i7 Iuliia Karpenko- h3ss="col-sm-6"6"6" add="contentndsu- esc"Ego-unistra" 6"6" ntheFélbcit ,aux Drs Christnce Basmadjis i7 Iuliia Karpenko qui v680ov> lEK s- voir décerner ln> Sout- ti-RAdl TulocaAen Pus="blurLink( (JB Grmaé)pbgo-unistra" 6"6" add="contentndsu-imagf"0;">06invisible-xs invisiblmoi(">novemb, s="blurLink( E’anthranoïdes cont Eu genre Psorospermum (Hypericaceae) : Isoleiv> , a transng>> i2- ader:le-xs invisiblmoi(">octob, i0invisible-xs invisiblmoi(">octob, 01invisible-xs invisiblmoi(">octob, allrapeu/>et- (CNRS /sUniv338nsé EK Stras Dr Didier5Rog ti reçoi hof Novbrtiseng>01invisible-xs invisiblmoi(">octob, Sout- ti-RAdl tulocaAdl Pty of a repipbgo-unistra" 6"6" add="contentndsu-imagf"0;">18invisible-xs invisiblmoi(">statemb, et-aet- FL3 sur lns-depeules sou Sout- ti-RAdl tulocaAdl Pty of agnosi pbgo-unistra" 6"6" add="contentndsu-imagf"0;">i4invisible-xs invisiblmoi(">statemb, DechacMEK- aminng> stall/>et- ,pour de nouvCaux ptatMEK-pbgo-unistra" 6"6" add="contentndsu-imagf"0;">i0invisible-xs invisiblmoi(">juillet stall/>et- ,pour de nouvCaux ptatMEK- - h3ss="col-sm-6"6"6" add="contentndsu- esc"Ego-unistra" 6"6" ntheLn faiblfl4-5disponibilnsé EKs ptatMEK- le="lil ,,polymlores d’acMEK- aminng>, nteociéRAà unelgrctiK> Dr Gaëlle Blond récompenei1invisible-xs invisiblmoi(">juin S968089 aournel! >07- ader:le-xs invisiblmoi(">avril aournel! > aournel! » esulun cycln EK webcastchentre 09680tif>et-a Plu822 insebito [dlasNT, uid:82228/div [end] --> 66134 Msid=end15 66133/htmlspan>2015 Raw HTMLlco2rong:span>2015Tout-( ln d tualnsng>"ique-med tualns-(trga00000rcher dfn fa-plus-circonrga[ab anicontentbtn btn- efault btn-smication">Flux RSS"ique-meflux-rs(trga00000rcher dfn fa-rs(rg Raw HTMLlco2rong:spend15 [dlasNT, uid:82228/div [end] --> 66133/htmlspend15MedalnsrgMedalnsr />a[ab a[dlass="col-sm-6"add="contentcol-xs-6 text-left"E anique-mehttp://www.icfrc.fr/ication">ICFRCrgICFRCr />a[ab a[dlass="col-sm-a[dlass="col-sa[dlass="cola[dlass="colafoororss="col-sadd="contentcontainer text-cens-ologo-unistrathe-2%2ong>UMR 7200 - Lnboratoire d'Innovbr /> Tllrapeu/>et- -le-xs invisiblcopyright"E/li4-/li7- ader: -le-xs invisibldroitsrgTou( droits résebvng>a[ader: -lUniv338nsé EK Strass="col-sm-6"Faculté EK pus="blifA- 74 rout-lEu Rh22 - CS 60024 - 67401 Illkirch Cedex > Tél. +33 3 68 85 42 20
s="col-sm-6"Ré9lnsé5par la anique-mehttp://typodun.uni2%29.frication">Kit compostis- - Cepeule WebDSloDirec benlEKa usagfslEu numériet-a[ab (DUN) -le-xs >anique-mepldn- u-sito/iconfocuentblurLink(this);">Plti du sitoa[ab -le ader: -xs >anique-meiv> -legtris/iconfocuentblurLink(this);">Mv> léghris- ab -le ader: -xs >anique-mecredits/iconfocuentblurLink(this);">Créditsa[ab "c